Gallbladder Removal Permanently Rewires Your Gut Microbiome, and the Risks Go Beyond Digestion

Roughly 700,000 Americans have their gallbladder removed every year, most of them for gallstones, and the surgery is widely regarded as safe and routine. What gets far less attention is what happens in the gut afterward. A new review published in Translational Gastroenterology and Hepatology synthesizes more than a decade of research on how cholecystectomy (surgical removal of the gallbladder) reshapes the gut microbiome in ways that may raise the long-term risk of colorectal cancer, irritable bowel syndrome, and early liver disease. The findings are emerging rather than definitive, but for the millions of people living post-cholecystectomy who are still dealing with digestive symptoms, the picture is worth understanding.

Key takeaways:

• Cholecystectomy disrupts the normal pulsed release of bile acids, driving measurable shifts in gut bacteria within three months of surgery.
• The resulting microbial changes reduce protective short-chain fatty acids, elevate toxic secondary bile acids, and weaken the gut barrier.
• Conditions including IBS, post-surgical diarrhea, fatty liver disease, and colorectal cancer are all associated with post-cholecystectomy dysbiosis, though causal links in humans remain under investigation.
• Diet, particularly high fat intake, significantly accelerates these microbial disruptions after surgery.

How Gallbladder Removal Disrupts the Bile Acid-Microbiome Balance

Cholecystectomy triggers gut dysbiosis (an imbalance in the microbial community) by permanently changing how bile acids enter the intestine. Normally, the gallbladder stores and concentrates bile, releasing it in a bolus when you eat a fatty meal. After removal, bile trickles continuously into the small intestine in low volumes. Approximately 85% of primary bile acids are ordinarily stored in the gallbladder; without it, that reservoir disappears, and the downstream chemistry changes profoundly.

The review synthesizes evidence showing that gut bacteria respond to this new bile environment within as little as three months. Genera that thrive on bile, particularly Bacteroides, Parabacteroides, and Clostridium, become enriched. These microbes carry an enzyme called bile salt hydrolase (BSH), which modifies primary bile acids into forms that are more water-soluble and less antimicrobial, allowing bile-tolerant species to proliferate. The same genera then convert those modified bile acids into secondary bile acids, specifically deoxycholic acid (DCA) and lithocholic acid (LCA), which are hydrophobic and cytotoxic. Elevated DCA and LCA are a central thread running through nearly every downstream risk described in the review.

Earlier research from Frontiers in Microbiology found that cholecystectomy eliminated aging-associated commensal microbiota and identified bile acid-metabolizing bacteria as contributors to elevated secondary bile acids, corroborating the mechanism the review describes.

What the Microbial Shift Costs: Butyrate, Barrier Integrity, and Systemic Inflammation

The enrichment of bile-tolerant bacteria comes at the expense of microbes that keep the gut lining healthy. SCFA-producing genera, including Faecalibacterium and Roseburia, are consistently reduced after cholecystectomy. SCFAs (short-chain fatty acids) are the primary energy source for colonocytes, the cells lining the colon. When butyrate, the most important SCFA for colon health, falls, colonocytes are starved, tight junction proteins such as ZO-1 and occludin decrease, and the gut barrier becomes leaky. Bifidobacterium also declines, removing an important supplier of acetate and lactate that butyrate-producing bacteria depend on.

The review describes a cascade from there: a leaky gut allows bacterial lipopolysaccharide (LPS) to translocate into systemic circulation, provoking inflammatory signals. Elevated secondary bile acids simultaneously disrupt a signaling pathway called FXR-FGF15 (a receptor-hormone axis that normally regulates bile acid synthesis and fat metabolism), which the review links to upregulated hepatic bile acid production and accelerated fat accumulation in liver cells. In animal models, this translated to elevated TNF-alpha, liver inflammation, and early-stage non-alcoholic fatty liver disease (NAFLD). High-fat diet consumption after surgery accelerated all of these changes, producing earlier and more severe metabolic disturbances including insulin resistance.

IBS, Diarrhea, and the Serotonin Connection

For people already managing irritable bowel syndrome, or who develop new gut symptoms after gallbladder removal, the review offers a plausible mechanism. Post-cholecystectomy diarrhea (PCD) affects a meaningful subset of patients and is characterized by altered microbial diversity, reduced Lactobacillus and Lactococcus, and increased Clostridium and Prevotella. Elevated secondary bile acids in these patients appear to stimulate serotonin production in the colon, accelerating intestinal transit and secretion, which produces chronic loose stools.

A study in Virulence found that altered gut microbiota after cholecystectomy drives post-cholecystectomy diarrhea through precisely this mechanism: secondary bile acids in the colon stimulate colonic serotonin and increase motility. A separate meta-analysis covering more than 3.5 million patients examined the association between IBS and gallbladder removal, noting that altered bile acid metabolism and microbial changes post-surgery may contribute to IBS symptoms in susceptible individuals. If you had IBS before surgery, or have developed persistent diarrhea or bowel irregularity since, the dysbiosis pathway is worth raising with your gastroenterologist.

The Colorectal Cancer Signal Researchers Are Still Untangling

Perhaps the most striking association in the review is between cholecystectomy and colorectal cancer, particularly right-sided colon cancer. The microbial profile of long-term post-cholecystectomy patients closely resembles that of colorectal cancer patients: enriched in pks-positive E. coli strains, which secrete a genotoxin called colibactin that directly damages DNA, and in Megamonas funiformis, a species associated with CRC progression. In antibiotic-treated mice lacking gut microbiota, cholecystectomy did not induce colorectal cancer, which the review interprets as evidence that dysbiosis, not the bile acid changes alone, drives the risk.

Research published in PubMed found that long-term cholecystectomy produces a gut microbiota profile resembling colorectal cancer patients, adding clinical depth to the mechanistic picture. A Frontiers in Oncology review similarly concluded that the colorectal cancer risk after cholecystectomy involves complex microbial mechanisms that are not yet fully mapped in humans. The causal link remains theoretical for now: most human data come from observational and case-control studies that cannot fully exclude confounding from diet, antibiotic use, or metabolic status, and the review is explicit that definitive causal evidence in humans is still lacking.

What the Evidence Does and Does Not Support for Post-Cholecystectomy Patients

The review points to diet as the most powerful modifiable lever. A high-fat diet after surgery accelerates dysbiosis and worsens inflammatory and metabolic markers; conversely, dietary composition appears to be a stronger determinant of microbiome health than pharmacological interventions. Bile acid sequestrants such as cholestyramine, which bind intestinal bile acids, partially restored microbial richness in one animal study, but evidence is limited to that single model with an unspecified dose, so it cannot be recommended as a clinical strategy based on current data. No probiotic or supplement intervention is established as proven for reversing post-cholecystectomy dysbiosis in humans.

If you have had your gallbladder removed and are experiencing persistent digestive symptoms, fatigue, or unexplained metabolic changes, this research provides a plausible biological framework worth discussing with a physician, not a prescription for self-treatment. The review identifies several gaps that future work needs to close: most studies used 16S rRNA sequencing, which has limited resolution; metabolomics data are sparse; and follow-up durations across studies are inconsistent, making it hard to track how the microbiome evolves over years rather than months.

Common Questions

Does everyone who has their gallbladder removed develop gut dysbiosis? Not necessarily to the same degree. The review notes that patients with pre-existing dysbiosis from gallstones show faster and more pronounced post-surgical microbial shifts. Individual factors including diet, antibiotic history, and metabolic status also influence how significantly the microbiome is disrupted.

How soon after cholecystectomy do microbiome changes appear? Beta diversity shifts, meaning changes in the overall composition of the microbial community, are detectable as early as three months post-surgery. Alpha diversity, which measures species richness within an individual, initially remains stable due to functional redundancy among gut microbes, but progressively declines over longer follow-up periods.

Is post-cholecystectomy diarrhea a microbiome problem or just a bile acid problem? Both are intertwined. Altered bile acid flow changes which bacteria thrive, and those bacteria then amplify secondary bile acid production, which stimulates serotonin in the colon and speeds up gut transit. Treating just the bile acids without addressing the microbiome may explain why outcomes from sequestrants are only partial.

Should post-cholecystectomy patients get colorectal cancer screening earlier? The review raises the association but stops short of recommending changed screening intervals, as the causal link in humans is not yet established. This is a question worth raising directly with your doctor, particularly if you have other colorectal cancer risk factors.

References

1. Krerkrit Kijpongpans, Nipon Chattipakorn, Siriporn C. Chattipakorn (2026). Cholecystectomy-induced gut dysbiosis and its consequences: bridging animal models and clinical outcomes in narrative review. Translational Gastroenterology and Hepatology. https://doi.org/10.21037/tgh-2026-0007
2. Wenxue Wang, Junfeng Wang, Julan Li, et al. (2018). Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2018.01402
3. Yayun Xu, Jianfa Wang, Xubo Wu, et al. (2023). Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin. Gut Microbes. https://doi.org/10.1080/19490976.2023.2168101
4. Jeongin Ra, Shivani Rao, Prakash V. A. K. Ramdass (2026). Cholecystectomy and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 3,511,681 Patients. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15145392
5. Xiecheng Zhou, Liang Xu, Qixing Zhang, Wenqi Chen, Hongwei Xie (2024). The impact of long-term (≥5 years) cholecystectomy on gut microbiota changes and its influence on colorectal cancer risk: based on 16S rDNA sequencing analysis. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000002827
6. Progress in the Study of Colorectal Cancer Caused by Altered Gut Microbiota After Cholecystectomy – Frontiers. frontiersin.org. https://www.frontiersin.org/articles/10.3389/fonc.2023.1311054/full